Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Takeda Pharmaceutical Company ( (TAK) ) has provided an update.
On July 9, 2025, Takeda Pharmaceutical Company released its Corporate Governance Report, highlighting its adherence to the Corporate Governance Code and its commitment to enhancing corporate value through sound decision-making and transparency. The report emphasizes Takeda’s strategies for shareholder engagement, diversity in its workforce, and sustainability initiatives, which are integral to its long-term business strategy and stakeholder relations.
The most recent analyst rating on (TAK) stock is a Hold with a $13.40 price target. To see the full list of analyst forecasts on Takeda Pharmaceutical Company stock, see the TAK Stock Forecast page.
Spark’s Take on TAK Stock
According to Spark, TipRanks’ AI Analyst, TAK is a Outperform.
Takeda Pharmaceutical Company demonstrates strong financial performance, driven by consistent revenue and profit growth, a solid balance sheet, and effective cash flow management. While the company’s technical indicators show moderate bullish momentum, the high P/E ratio raises valuation concerns. The mixed earnings call highlights both promising product launches and challenges from generic competition. Overall, Takeda’s strong fundamentals and promising pipeline are somewhat tempered by valuation and competitive pressures, resulting in an overall stock score of 71.
To see Spark’s full report on TAK stock, click here.
More about Takeda Pharmaceutical Company
Takeda Pharmaceutical Company Limited is a global, R&D-driven biopharmaceutical company headquartered in Tokyo, Japan. The company focuses on providing better health for people and a brighter future for the world, operating in approximately 80 countries and regions. Takeda is committed to diversity, sustainability, and transparent corporate governance, ensuring rigorous compliance and risk management.
Average Trading Volume: 2,094,997
Technical Sentiment Signal: Buy
Current Market Cap: $47.62B
See more insights into TAK stock on TipRanks’ Stock Analysis page.